Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 2OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia 26Lymphoma, Large B-Cell, Diffuse 22Breast Neoplasms 21Lymphoma, Follicular 18Leukemia, Myeloid, Acute 18Burkitt Lymphoma 16Multiple Myeloma 15Lymphoma, Non-Hodgkin 15Lymphoma, Mantle-Cell 14Leukemia, Lymphocytic, Chronic, B-Cell 13Hodgkin Disease 13Lymphoma, Large-Cell, Immunoblastic 12Neuroblastoma 11Melanoma 11Myelodysplastic Syndromes 10Lymphoma, B-Cell, Marginal Zone 10Neoplasms, Plasma Cell 9Sarcoma 8Leukemia, Myeloid, Chronic-Phase 8Neutropenia 7Central Nervous System Neoplasms 7Myeloproliferative Disorders 6Medulloblastoma 6Leukemia, Myelomonocytic, Acute 6Congenital Abnormalities 6Waldenstrom Macroglobulinemia 5Neoplasms 5Leukemia, Myelomonocytic, Chronic 5

Interventions

Doxorubicin 3pazopanib 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Ifosfamide 2sapanisertib 1romidepsin 1pegfilgrastim 1metarrestin 1cixutumumab 1Temozolomide 1Specimen Handling 1Sorafenib 1Radiation 1Nivolumab 1Molecular Diagnostic Techniques 1Microarray Analysis 1MLN 8237 1Ipilimumab 1HhAntag691 1Filgrastim 1Etoposide 1Diathermy 1CTLA-4 Antigen 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neurofibrosarcoma × Filgrastim × Clear all
NCT00004853 2019-11-12

Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
34 enrolled
Sarcoma

Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Sarcoma, Synovial, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡